NEW YORK (GenomeWeb News) – Transgenomic today said that it has signed an agreement to acquire the biorepository assets of Gene Logic for $250,000 in cash.

The biorepository contains 60,000 human tissue samples and extracted DNA specimens with linked clinical information and will be used to validate Transgenomic's assays. Specifically, Omaha, Neb.-based Transgenomic said that it will use the samples in development and validation of its Reveal family of Ice Cold-PCR-based oncology assays as well as its Wave MCE System and Surveyor Scan Mutation Detection Kits.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.

Oct
02
Sponsored by
Roche

In the last few years several molecular testing methodologies — such as immunohistochemistry, PCR, and sequencing — have been approved by the US Food and Drug Administration to aid in the management of patients with lung cancer.  

Oct
10
Sponsored by
Philips Genomics

This webinar will provide a first-hand look at how the Dana-Farber Cancer Center is adapting its oncology care strategy in light of the rapidly evolving molecular landscape.